Overview of Biomarkers and Surrogate Endpoints in Drug Development

There are numerous factors that recommend the use of biomarkers in drug development including the ability to provide a rational basis for selection of lead compounds, as an aid in determining or refining mechanism of action or pathophysiology, and the ability to work towards qualification and use of...

Full description

Bibliographic Details
Main Author: John A. Wagner
Format: Article
Language:English
Published: Hindawi Limited 2002-01-01
Series:Disease Markers
Online Access:http://dx.doi.org/10.1155/2002/929274